NATCO Pharma Ltd.
Share Price Target & Analysis

NSE:NATCOPHARM

790.2

VWAP

792.05

Open

787.55

Close

800.9

High

779.5

Low

1226.8

52 Week High

782.40 ⇩
-5.15 (-0.65%)

NATCOPHARM

(PHARMA)
1.9% Momentum

Watch Carefully

773.6

52 Week Low

82.14

EPS

17.21

PE

1.55

PB

Deluxe
Quality

Steel
Valuation

#Analysis

NSE: NATCOPHARM Share Price Financial Analysis & Valuation

NATCO Pharma Ltd. (NATCOPHARM) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Small Cap company with Market Capitalization of Rs 16084.6 (in Cr). Total number of free float shares are 18.2 (in Lacs). NATCO Pharma Ltd. is listed on NSE with Exchange ID - INE987B01026 and trading code is NSE:NATCOPHARM with short name Natco Pharma.

In the past 1 year, NATCO Pharma Ltd. has declared an equity dividend of Rs 0.64 per share. At the current share price of NATCOPHARM at Rs 782.40, this results in a dividend yield of 0.08 %.

As per the Fundamental Analysis of NSE:NATCOPHARM, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine NATCOPHARM underlying value and future prospects. All of this data is available in NATCOPHARM financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:NATCOPHARM, it is clearly understood that NATCOPHARM is Deluxe performer in terms of earnings and profit margins with an EPS of 82.14. NSE:NATCOPHARM book value per share as of today is 505. The current price to book ratio for NATCOPHARM as of Oct 31, 2026 is 1.55.

Valuation of the Stock: The current valuation of NATCOPHARM stock is like Steel which means currently the stock is Moderately Priced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of NATCOPHARM whether to BUY this stock at current valuation. The delivery percentage of NATCOPHARM is 121588% is very crucial parameter which shows that 121588% investors are anticipating that the price of NATCOPHARM share should go up with VWAP at 790.2.

Now, the main question is whether to BUY or SELL, NSE:NATCOPHARM at current valuation.
As per latest Analysis No. #4581:-

⇑ STRONG BUY NATCOPHARM if All Greens

⇗ BUY NATCOPHARM (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD NATCOPHARM (With Stop Loss) if only 1 Green

⇘ SELL NATCOPHARM if NO Green Indicator

NSE: NATCOPHARM Share Price Today (Oct 31, 2026)

(NATCO Pharma Ltd. Daily Analysis on the basis of NATCOPHARM Intraday Graph & Trend)

NATCO Pharma Ltd. share price moved Down by -0.65% from its previous close of Rs 787.55. NATCOPHARM stock last traded price is 782.40. NATCOPHARM share price trend is Down with a total of 321547 stocks traded till now. It has touched an intraday high of Rs 800.9 and an intraday low of Rs 779.5. The NATCOPHARM trading at 782.40, Down by Rs. -5.15, or -0.65 percent which suggests that most of the Traders are anticipating that the price of NATCOPHARM share should go Down.

NSE: NATCOPHARM Share Price Tomorrow Prediction

(NATCO Pharma Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of NATCOPHARM)

NATCO Pharma Ltd. share price moved Down by -0.65%. NATCOPHARM share price short term trend is Down. It suggests that NATCOPHARM Share Price for Tomorrow remains the same with VWAP at 790.2 will be treated as stop loss for intraday traders. NATCO Pharma Ltd. Long term investors can follow the NATCOPHARM long term trend as mentiond in future forecast table.

NSE Code

NSE: NATCOPHARM

NATCOPHARM Share Price Today

 782.40

NATCOPHARM Share Price Target Prediction for 2026 ^

 811 - 1061.6

NATCOPHARM Share Price Target Prediction for 2027*^

 1061.6 - 1313.4

NATCOPHARM Share Price Target Prediction for 2028*^

 1313.4 - 1405.3

NATCOPHARM Share Price Target Prediction for 2029*^

 1476

NATCOPHARM Share Price Target Prediction for 2030*^

 1518

NATCOPHARM Share Price Target Prediction for 2035*^

 1654
NATCOPHARM Current Book Value
502.5

*NATCO Pharma Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^NATCOPHARM share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

NATCOPHARM Technical Analysis

Candlestick Pattern: @826.3

NATCOPHARM Moving Averages

BUY (0) NEUTRAL (0) SELL (14)
MA Simple Action S1 Expo Action E2
MA_5 831.46 SELL 832.16 SELL
MA_12 847.41 SELL 847.78 SELL
MA_20 865.3 SELL 860.37 SELL
MA_32 887.89 SELL 880.16 SELL
MA_50 909.61 SELL 897.75 SELL
MA_100 953.65 SELL 923.39 SELL
MA_200 945.67 SELL 946.29 SELL

NATCOPHARM Trend Oscillators

BUY (0) NEUTRAL (1) SELL (3)
Trend Oscillators Value Action
Bollinger Bands 865.3 Downtrend
MACD -2.01 SELL
ADX 17.29 NO or Weak Trend
DMI (+/-) 11.47 / 21.5 Downtrend

NATCOPHARM Momentum Oscillators

BUY (2) NEUTRAL (6) SELL (4)
Momentum Oscillators Value Action
RSI 31.4 Neutral
STOCHASTIC_K (Fast) 26.78 Neutral
STOCHASTIC_D (Slow) 23.53 Neutral
CCI -106.81 SELL
PSAR 853.42 SELL
TRUE RANGE 23.7 BUY
ATR 22.22 BUY
WILLIAMS R -86.91 Oversold
TRIX 0 Neutral
STOCHASTIC RSI K 44.31 Neutral
STOCHASTIC RSI D 60.93 Neutral
MOMENTUM -80.7 SELL

NATCOPHARM Last 1 Year Trend

Duration Value
1 Year -3.42%
3 Months -4.47%
1 Month -8.9%
1 Week -2.01%

NATCOPHARM Technical Analysis Summary

Updated on 2026-09-09
Action Overall (%)
BUY 7%
NEUTRAL / HOLD 23%
SELL 70%

(powered by Zerodha)

Most popular Questions & Answers about NATCOPHARM

NATCO Pharma Ltd. Frequently Asked Questions (FAQs)

NATCO Pharma Ltd. stock last traded price is 782.40. NATCOPHARM share price moved Down by -0.65% from its previous close of Rs 787.55.

NATCO Pharma Ltd. share price trend is Down with a total of 321547 stocks traded till now. It has touched an intraday high of Rs 1239.068 and an intraday low of Rs 779.5. The NATCOPHARM trading at 782.40, Down by Rs. -5.15, or -0.65 percent which suggests that most of the Traders are anticipating that the price of NATCOPHARM share should go Down and the Stop Loss will be around 790.2.

The market cap of NATCO Pharma Ltd. is ₹16084.6 (in Cr) as of Oct 30, 2026.

The current price to earning ratio for NATCO Pharma Ltd. as of Oct 30, 2026 is 17.21.

The current price to book ratio for NATCO Pharma Ltd. as of Oct 30, 2026 is 1.55.

The highest price of NATCO Pharma Ltd. stock is ₹1226.8 in the last 52-week.

The lowest price of NATCO Pharma Ltd. stock is ₹773.6 in the last 52-week.

NATCO Pharma Ltd. share trading at ₹782.40, Down by Rs. -5.15, or -0.65 percent which suggests that most of the traders are anticipating that the price of NATCOPHARM share should go Down.

In 2026, Stock price target for NATCO Pharma Ltd. (NATCOPHARM) will be around ₹811 on downside and ₹1061.6 on upside. NATCO Pharma Ltd. share price target is based on current financial year earings of the company.

In 2027, Stock price target for NATCO Pharma Ltd. (NATCOPHARM) will be around ₹1061.6 on downside and ₹1313.4 on upside. NATCO Pharma Ltd. share price target is based on forecasted future earnings of the company.

In 2028, Stock price target for NATCO Pharma Ltd. (NATCOPHARM) will be around ₹1313.4 on downside and ₹1405.3 on upside. NATCO Pharma Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for NATCO Pharma Ltd. (NATCOPHARM) will be around ₹1518 NATCO Pharma Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of NATCOPHARM.

The price of NATCO Pharma Ltd. (NATCOPHARM) shares moved by -0.65%. The short-term trend for NATCOPHARM share price is Down. It implies that the share price of NATCOPHARM will stay the same tomorrow and that intraday traders should treat VWAP at 790.2 as a stop loss. Investors with a long-term outlook can track NATCOPHARM long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of NATCOPHARM stock is 984.9. Compared to the current market price of 782.40 INR, the NATCOPHARM stock is Undervalued by 20.6%.

As per the fundamental analysis of NATCO Pharma Ltd. (NATCOPHARM), it is of Deluxe quality in terms of earnings and profit margins with an EPS of 82.14. NATCO Pharma Ltd. book value per share as of today is 505. The current price to book ratio for NATCOPHARM as of Oct 31, 2026 is 1.55.


NSE:NATCOPHARM News & Other Useful Information about NATCOPHARM Share Price


Peer Comparison of NSE: NATCOPHARM

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1777.70 16.35 97.89
DIVISLAB 9780.00 115.55 663.06
MEDICAMEQ 256.20 12.15 201.07
CIPLA 1378.90 51.67 434.02
DRREDDY 1352.00 53.19 380.63
TORNTPHARM 4613.40 87.32 235.7
BIOCON 351.80 1.27 166.51
LUPIN 2011.00 154.86 718.32
ALKEM 5113.50 212.33 1218.48
AUROPHARMA 1681.40 46.49 403.84
ABBOTINDIA 25635.00 766.11 2448.41
GLAXO 2494.30 63.65 147.25
IPCALAB 1927.80 56.72 329.23
LAURUSLABS 2405.50 20.74 102.57
LALPATHLAB 1906.40 39.68 157.23
PFIZER 3687.80 170.54 963.41
AJANTPHARM 3508.80 89.3 363.23
SANOFI 3204.10 158.05 332.96
NATCOPHARM 782.40 82.14 505
APLLTD 797.85 48.4 295.69
JBCHEPHARM 2408.90 54.16 251.48
GLENMARK 2298.70 1.24 881.78
AAREYDRUGS 106.26 2.39 53.38
JUBLPHARMA 923.80 4.35 145.63
SPARC 176.46 48.14 40.45
GRANULES 839.75 23.25 180.42
ASTRAZEN 6364.50 86.44 364.29
CAPLIPOINT 2325.60 55.52 285.6
FDC 377.00 21.19 161.21
HIKAL 211.58 9.34 96.63
Updated at: 2026-10-30 15:57:43

Feel free to contact us, in case of any queries.

Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2579.40 -28.50 (-1.09%) | ADANIPORTS 1850.00 -22.00 (-1.18%) | APOLLOHOSP 8448.00 248.00 (3.02%) | ASIANPAINT 2320.00 18.00 (0.78%) | AXISBANK 1217.00 -8.00 (-0.65%) | BAJAJ-AUTO 10350.00 -33.00 (-0.32%) | BAJAJFINSV 1667.60 -0.40 (-0.02%) | BAJFINANCE 939.10 0.20 (0.02%) | BEL 369.90 -0.10 (-0.03%) | BHARTIARTL 1973.70 1.60 (0.08%) | CIPLA 1378.90 20.90 (1.54%) | COALINDIA 389.00 -4.10 (-1.04%) | DRREDDY 1352.00 7.00 (0.52%) | EICHERMOT 7220.00 -18.00 (-0.25%) | GRASIM 2981.40 48.60 (1.66%) | HCLTECH 1428.10 24.20 (1.72%) | HDFCBANK 692.80 9.50 (1.39%) | HDFCLIFE 524.90 7.90 (1.53%) | HINDALCO 884.70 -1.60 (-0.18%) | HINDUNILVR 1864.60 6.40 (0.34%) | ICICIBANK 1398.00 11.40 (0.82%) | INDIGO 4877.60 202.60 (4.33%) | INFY 1185.00 38.50 (3.36%) | ITC 265.60 0.60 (0.23%) | JIOFIN 204.50 -2.50 (-1.21%) | JSWSTEEL 1246.00 -9.40 (-0.75%) | KOTAKBANK 461.60 2.60 (0.57%) | LT 3871.70 34.60 (0.9%) | M&M 2840.30 -49.70 (-1.72%) | MARUTI 11397.00 -29.00 (-0.25%) | MAXHEALTH 860.00 8.85 (1.04%) | NESTLEIND 1167.00 -21.60 (-1.82%) | NTPC 316.25 5.75 (1.85%) | ONGC 225.39 -0.40 (-0.18%) | POWERGRID 265.00 5.00 (1.92%) | RELIANCE 1164.90 -2.50 (-0.21%) | SBILIFE 1658.60 6.60 (0.4%) | SBIN 961.85 -10.05 (-1.03%) | SUNPHARMA 1777.70 16.70 (0.95%) | TATACONSUM 1025.90 4.90 (0.48%) | TATASTEEL 167.60 -1.86 (-1.1%) | TCS 2502.60 24.60 (0.99%) | TECHM 1790.80 21.20 (1.2%) | TITAN 4436.50 2.50 (0.06%) | TMPV 265.40 -0.60 (-0.23%) | TRENT 3017.30 155.60 (5.44%) | ULTRACEMCO 11045.00 -130.00 (-1.16%) | WIPRO 198.31 8.21 (4.32%) |
Top